ADLAI NORTYE LTD-ADR (ANL) Fundamental Analysis & Valuation

NASDAQ:ANL • US00704R1095

Current stock price

16.6 USD
+0.59 (+3.69%)
At close:
17.3 USD
+0.7 (+4.22%)
After Hours:

This ANL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ANL Profitability Analysis

1.1 Basic Checks

  • In the past year ANL has reported negative net income.
  • ANL had negative earnings in each of the past 5 years.
  • ANL had a negative operating cash flow in each of the past 5 years.
ANL Yearly Net Income VS EBIT VS OCF VS FCFANL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -72.00%, ANL is not doing good in the industry: 65.89% of the companies in the same industry are doing better.
  • ANL has a worse Return On Equity (-654.83%) than 79.46% of its industry peers.
Industry RankSector Rank
ROA -72%
ROE -654.83%
ROIC N/A
ROA(3y)-79.22%
ROA(5y)-90.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANL Yearly ROA, ROE, ROICANL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ANL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANL Yearly Profit, Operating, Gross MarginsANL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ANL Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ANL remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for ANL is higher compared to a year ago.
ANL Yearly Shares OutstandingANL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
ANL Yearly Total Debt VS Total AssetsANL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -2.45, we must say that ANL is in the distress zone and has some risk of bankruptcy.
  • ANL has a Altman-Z score (-2.45) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 5.59 is on the high side and indicates that ANL has dependencies on debt financing.
  • ANL has a worse Debt to Equity ratio (5.59) than 81.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.59
Debt/FCF N/A
Altman-Z -2.45
ROIC/WACCN/A
WACCN/A
ANL Yearly LT Debt VS Equity VS FCFANL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that ANL should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.03, ANL is doing worse than 87.21% of the companies in the same industry.
  • A Quick Ratio of 1.03 indicates that ANL should not have too much problems paying its short term obligations.
  • ANL has a worse Quick ratio (1.03) than 86.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
ANL Yearly Current Assets VS Current LiabilitesANL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ANL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.51% over the past year.
EPS 1Y (TTM)78.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -13.67% on average over the next years. This is quite bad
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y71.97%
EPS Next 2Y32%
EPS Next 3Y16.88%
EPS Next 5Y-13.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ANL Yearly Revenue VS EstimatesANL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ANL Yearly EPS VS EstimatesANL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. ANL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ANL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANL Price Earnings VS Forward Price EarningsANL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANL Per share dataANL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • ANL's earnings are expected to grow with 16.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32%
EPS Next 3Y16.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ANL Dividend Analysis

5.1 Amount

  • ANL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ANL Fundamentals: All Metrics, Ratios and Statistics

ADLAI NORTYE LTD-ADR

NASDAQ:ANL (4/20/2026, 8:00:01 PM)

After market: 17.3 +0.7 (+4.22%)

16.6

+0.59 (+3.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-01
Earnings (Next)N/A
Inst Owners6.19%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap881.08M
Revenue(TTM)N/A
Net Income(TTM)-51.87M
Analysts82.86
Price Target28.9 (74.1%)
Short Float %7.49%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.6%
PT rev (3m)214.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)16.38%
EPS NY rev (3m)31.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-20.4%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 111.23
P/tB 111.64
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -72%
ROE -654.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-79.22%
ROA(5y)-90.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 5.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z -2.45
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)50.59%
Cap/Depr(5y)120.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.7%
EPS Next Y71.97%
EPS Next 2Y32%
EPS Next 3Y16.88%
EPS Next 5Y-13.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.53%
OCF growth 3YN/A
OCF growth 5YN/A

ADLAI NORTYE LTD-ADR / ANL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ADLAI NORTYE LTD-ADR (ANL) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ANL.


What is the valuation status for ANL stock?

ChartMill assigns a valuation rating of 0 / 10 to ADLAI NORTYE LTD-ADR (ANL). This can be considered as Overvalued.


Can you provide the profitability details for ADLAI NORTYE LTD-ADR?

ADLAI NORTYE LTD-ADR (ANL) has a profitability rating of 0 / 10.


How financially healthy is ADLAI NORTYE LTD-ADR?

The financial health rating of ADLAI NORTYE LTD-ADR (ANL) is 1 / 10.